131 related articles for article (PubMed ID: 36656678)
1. Detemir improves diabetic regulation in poorly controlled diabetic dogs with concurrent diseases.
Harris-Samson AR; Rand J; Ford SL
J Am Vet Med Assoc; 2023 Jan; 261(3):327-335. PubMed ID: 36656678
[TBL] [Abstract][Full Text] [Related]
2. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
3. Detemir insulin for the treatment of diabetes mellitus in dogs.
Fracassi F; Corradini S; Hafner M; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
J Am Vet Med Assoc; 2015 Jul; 247(1):73-8. PubMed ID: 26086231
[TBL] [Abstract][Full Text] [Related]
4. [RESOLUTE Study in the Czech Republic: insulin glargine improves the compensation of type 2 diabetes in patients with unsatisfactory results of therapy with a combination of insulin detemir and oral antidiabetics. Results of the nonintervention RESOLUTE Project in the Czech Republic].
Kvapil M
Vnitr Lek; 2013 Sep; 59(9):800-6. PubMed ID: 24073952
[TBL] [Abstract][Full Text] [Related]
5. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
Hollander P; Cooper J; Bregnhøj J; Pedersen CB
Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
[TBL] [Abstract][Full Text] [Related]
6. Insulin detemir treatment in diabetic cats in a practice setting.
Hoelmkjaer KM; Spodsberg EM; Bjornvad CR
J Feline Med Surg; 2015 Feb; 17(2):144-51. PubMed ID: 24938314
[TBL] [Abstract][Full Text] [Related]
7. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.
Russell-Jones D; Simpson R; Hylleberg B; Draeger E; Bolinder J
Clin Ther; 2004 May; 26(5):724-36. PubMed ID: 15220016
[TBL] [Abstract][Full Text] [Related]
8. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
Heller S; Koenen C; Bode B
Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
[TBL] [Abstract][Full Text] [Related]
9. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Hemmingsen B; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
[TBL] [Abstract][Full Text] [Related]
10. Long-acting insulin analogues and diabetic retinopathy: a retrospective cohort study.
Lin JC; Shau WY; Lai MS
Clin Ther; 2014 Sep; 36(9):1255-68. PubMed ID: 25082730
[TBL] [Abstract][Full Text] [Related]
11. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.
Rosenstock J; Davies M; Home PD; Larsen J; Koenen C; Schernthaner G
Diabetologia; 2008 Mar; 51(3):408-16. PubMed ID: 18204830
[TBL] [Abstract][Full Text] [Related]
12. Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects?
Valensi P; Cosson E
Diabetes Metab; 2005 Sep; 31(4 Pt 2):4S34-4S39. PubMed ID: 16389896
[TBL] [Abstract][Full Text] [Related]
13. Detemir vs Glargine: Comparison of Inpatient Glycemic Control.
Capson J; Cade K; Avanesyan A
J Am Osteopath Assoc; 2019 Feb; 119(2):89-95. PubMed ID: 30688354
[TBL] [Abstract][Full Text] [Related]
14. Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin detemir using continuous glucose monitoring: a randomized, cross-over, pilot study.
Takahashi H; Nishimura R; Onda Y; Ando K; Tsujino D; Utsunomiya K
Expert Opin Pharmacother; 2017 Mar; 18(4):335-342. PubMed ID: 28234565
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial.
Zhang T; Lin M; Li W; Fan X; Du T; Zhao Y; Zhang X
Adv Ther; 2016 Feb; 33(2):178-85. PubMed ID: 26809253
[TBL] [Abstract][Full Text] [Related]
16. Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study.
King AB
Diabetes Obes Metab; 2009 Jan; 11(1):69-71. PubMed ID: 19120433
[TBL] [Abstract][Full Text] [Related]
17. Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and hypoglycaemic episodes when administered in addition to conventional oral anti-diabetic therapy in patients with type-2 diabetes.
Fakhoury W; Lockhart I; Kotchie RW; Aagren M; LeReun C
Pharmacology; 2008; 82(2):156-63. PubMed ID: 18679040
[TBL] [Abstract][Full Text] [Related]
18. Improved glycemic control with weight loss and a low risk of hypoglycemia with insulin detemir: insights from the Italian cohort of the PREDICTIVE study after 6-month observation in type 2 diabetic subjects.
Perriello G; Caputo S; De Pergola G; Di Carlo A; Grassi G; Lapolla A; Pata P; Solerte SB; Zaccardi F
Expert Opin Pharmacother; 2011 Nov; 12(16):2449-55. PubMed ID: 21988213
[TBL] [Abstract][Full Text] [Related]
19. Reliability of history and physical examination findings for assessing control of glycemia in dogs with diabetes mellitus: 53 cases (1995-1998).
Briggs CE; Nelson RW; Feldman EC; Elliott DA; Neal LA
J Am Vet Med Assoc; 2000 Jul; 217(1):48-53. PubMed ID: 10909446
[TBL] [Abstract][Full Text] [Related]
20. Insulin Therapy in Small Animals, Part 3: Dogs.
Fleeman L; Gilor C
Vet Clin North Am Small Anim Pract; 2023 May; 53(3):645-656. PubMed ID: 36906466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
